Suven Life Science's share price declined 5.67% to a low of Rs 308.05 on Thursday, after the company's net loss for the June quarter widened.
It reported a consolidated net loss of Rs 128 crore for the first quarter of FY27, compared with a loss of Rs 46 crore in the preceding quarter. Revenue increased to Rs 3.6 crore from Rs 1.5 crore on a sequential basis.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
As of 1:34 p.m., the scrip traded 4.44% lower at Rs 312.05 apiece on the NSE, as against marginal gains in the benchmark Nifty index.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
The stock has risen 86.86% year-to-date and 28% in the last 12 months.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
